Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study
PaperCitations, authors & open-access status
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2025 year and bronze oa status.
5
Citations
2025
Year
bronze
OA Status